MIG Fonds leads €65 million Series B financing of iOmx Therapeutics

MIG portfolio company AMSilk completes €29 million financing round

European innovation reaches EU population: MIG Fonds` portfolio company BioNTech achieves positive CHMP opinion for the first COVID-19 and mRNA vaccine